Your activity: 18 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Ruxolitinib: Drug information

Ruxolitinib: Drug information

Information for this drug is presented separately based upon the following methods of administration:

Topic 17096 Version 252.0